Literature DB >> 8117910

Marginal modeling of binary cross-over data.

M P Becker1, C C Balagtas.   

Abstract

A model specified in terms of linear models for marginal logits and linear models for log-odds ratios is proposed for the analysis of two-period binary cross-over experiments. Hypothesis testing and parameter estimation are facilitated by standard likelihood methodology. Two examples are used to illustrate how the model can be used to analyze two-period binary cross-over experiments. Results from a simulation study demonstrate that this approach to the analysis of binary cross-over data compares favorably with standard procedures, such as the Mainland-Gart test for a treatment difference, Prescott's test for a treatment difference, and the Hills-Armitage test for treatment-by-period interaction.

Entities:  

Mesh:

Year:  1993        PMID: 8117910

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  16 in total

Review 1.  Deep brain and cortical stimulation for epilepsy.

Authors:  Mathieu Sprengers; Kristl Vonck; Evelien Carrette; Anthony G Marson; Paul Boon
Journal:  Cochrane Database Syst Rev       Date:  2017-07-18

2.  Randomized, double-blinded, placebo-controlled crossover trial of treating erectile dysfunction with sildenafil after radiotherapy and short-term androgen deprivation therapy: results of RTOG 0215.

Authors:  Deborah Watkins Bruner; Jennifer L James; Charlene J Bryan; Thomas M Pisansky; Marvin Rotman; Thomas Corbett; Joycelyn Speight; Roger Byhardt; Howard Sandler; Søren Bentzen; Lisa Kachnic; Lawrence Berk
Journal:  J Sex Med       Date:  2011-01-14       Impact factor: 3.802

3.  Multivariate logistic regression with incomplete covariate and auxiliary information.

Authors:  Sanjoy K Sinha; Nan M Laird; Garrett M Fitzmaurice
Journal:  J Multivar Anal       Date:  2010-11-01       Impact factor: 1.473

Review 4.  Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis.

Authors:  Graziella Filippini; Silvia Minozzi; Francesca Borrelli; Michela Cinquini; Kerry Dwan
Journal:  Cochrane Database Syst Rev       Date:  2022-05-05

5.  Sensitivity analysis for non-monotone missing binary data in longitudinal studies: Application to the NIDA collaborative cocaine treatment study.

Authors:  Garrett M Fitzmaurice; Stuart R Lipsitz; Roger D Weiss
Journal:  Stat Methods Med Res       Date:  2018-08-27       Impact factor: 3.021

Review 6.  Short-acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus.

Authors:  Birgit Fullerton; Andrea Siebenhofer; Klaus Jeitler; Karl Horvath; Thomas Semlitsch; Andrea Berghold; Johannes Plank; Thomas R Pieber; Ferdinand M Gerlach
Journal:  Cochrane Database Syst Rev       Date:  2016-06-30

Review 7.  Recombinant factor VIIa concentrate versus plasma-derived concentrates for treating acute bleeding episodes in people with haemophilia and inhibitors.

Authors:  Davide Matino; Michael Makris; Kerry Dwan; Roberto D'Amico; Alfonso Iorio
Journal:  Cochrane Database Syst Rev       Date:  2015-12-16

Review 8.  Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

Authors:  Ole Jakob Storebø; Erica Ramstad; Helle B Krogh; Trine Danvad Nilausen; Maria Skoog; Mathilde Holmskov; Susanne Rosendal; Camilla Groth; Frederik L Magnusson; Carlos R Moreira-Maia; Donna Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Bente Forsbøl; Erik Simonsen; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2015-11-25

9.  Design, Analysis, and Reporting of Crossover Trials for Inclusion in a Meta-Analysis.

Authors:  Tianjing Li; Tsung Yu; Barbara S Hawkins; Kay Dickersin
Journal:  PLoS One       Date:  2015-08-18       Impact factor: 3.240

10.  Comparison of intervention effects in split-mouth and parallel-arm randomized controlled trials: a meta-epidemiological study.

Authors:  Violaine Smaïl-Faugeron; Hélène Fron-Chabouis; Frédéric Courson; Pierre Durieux
Journal:  BMC Med Res Methodol       Date:  2014-05-11       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.